Shanghai, China, September 15, 2022 – Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary
Shanghai, China, August 30, 2022 – Asieris Pharmaceuticals (stock code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment
Asieris Pharmaceuticals just issued its 2022 H1 Semi-Annual Report. Find these highlights from this report: You can also download and view these highlights in one file.
https://vimeo.com/742874665 Shanghai, China, August 24, 2022 – Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary
Contact us today for partnership opportunities
